SCHEMBL21783445

SCHEMBL21783445

COc1ccc(CN(Sc2cnc(F)c(Cl)c2)c2cccc(F)n2)c(OC)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 9/20 0.35
CYP3A4 P08684 9/20 0.35
CYP2D6 P10635 9/20 0.35
TSHR P16473 9/20 0.35
CYP2C19 P33261 8/20 0.35
ALDH1A1 P00352 5/20 0.35
CYP2C9 P11712 2/20 0.35
HIF1A Q16665 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
HSD17B10 Q99714 2/20 0.35
HTR2A P28223 1/20 0.35
SLC6A4 P31645 1/20 0.35
KCNH2 Q12809 1/20 0.35
CLK4 Q9HAZ1 4/20 0.35
LMNA P02545 4/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.34
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19634018 0.87 MEN1 (0.39) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL19634258 0.81 HTR2A (0.38) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL20256741 0.79 KMT2A (0.35) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL21783377 0.79 MEN1 (0.37) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL31018047 0.78 TP53 (0.39) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL21783443 0.78 TP53 (0.39) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL21783444 0.78 KMT2A (0.37) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL21794007 0.76 GAA (0.42) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL21783395 0.76 KMT2A (0.36) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL19634006 0.75 DHFR (0.36) CYP1A2CYP3A4CYP2D6TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020047323-A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2020-03-05 WO disclosed